Module 4 – July 2027, 5 – 9
Monday 5
|
Models of demyelinating CMT | Maurizio D’Antonio Biology of Myelin Unit, Division of Genetics and Cell Biology, Ospedale San Raffaele, Milano, Italy |
|
Models of motor neuronopathy | Charlotte Sumner Neurology and Neuroscience Johns Hopkins University School of Medicine Baltimore, USA |
|
Next generation sequencing: applications in clinical practice and gene discovery | Stephan Zuchner University of Miami Miller School of Medicine Miami, USA |
|
Interactive session |
Tuesday 6
|
Axonal neuropathies: all the novelties on pathogenesis, clinical features and treatments | Mary Reilly Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK |
|
Demyelinating neuropathies: all the novelties on pathogenesis, clinical features and treatments | Davide Pareyson Department of Neurodegenerative and Rare Diseases, Milan, Italy |
|
Ataxic neuropathies | Andrea Cortese Department of Neuromuscular Diseases, UCL, Queen Square Institute of Neurology |
|
Interactive session |
Wednesday 7
|
Amyloid neuropathies | Laura Obici Amyloidosis Research and Treatment Centre, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy |
|
Gene therapies in CMT | Kleopas Kleopa The Cyprus Institute of Neurology and Genetics |
Thursday 8
|
Preclinical models of spinal muscular atrophy | Stefania Corti |
|
Diagnosis and treatment of spinal muscular atrophy | Riccardo Masson |
|
Distal myopathies | Elena Pegoraro |
Friday 9
|
Pediatric CMT | Isabella Moroni Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy |
|
Neuropathies in rare and ultrarare disorders | Ettore Salsano |
|
Interactive sessions |


